A Clinical Study of TQB3616 Capsules Combined With Anlotinib Hydrochloride Capsules or Standard Chemotherapy Second-line and Above in the Treatment of Advanced Lung Cancer
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
EMD Serono
Massachusetts General Hospital
NuCana plc
University of Nebraska
Actuate Therapeutics Inc.
Gilead Sciences
BeiGene
M.D. Anderson Cancer Center
Thomas Jefferson University
IGM Biosciences, Inc.
Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS
CNAO National Center of Oncological Hadrontherapy
Centre Hospitalier Universitaire de Besancon
Handok Inc.
Alliance for Clinical Trials in Oncology
Alliance for Clinical Trials in Oncology
Dana-Farber Cancer Institute
Washington University School of Medicine
Immodulon Therapeutics Ltd
EpicentRx, Inc.
Memorial Sloan Kettering Cancer Center
Shanghai Jun Pai Ying Shi Therapeutics Co., Ltd.
Milton S. Hershey Medical Center
Sichuan Baili Pharmaceutical Co., Ltd.
Federation Francophone de Cancerologie Digestive
Kyowa Kirin Co., Ltd.
Jiangsu Simcere Pharmaceutical Co., Ltd.
Sun Yat-sen University
Albert Einstein College of Medicine
Eisai Inc.
UNICANCER
Gradalis, Inc.
Sun Yat-sen University
Peking University
Yale University
Augusta University
EpicentRx, Inc.
Boehringer Ingelheim
NSABP Foundation Inc
Fox Chase Cancer Center
AbbVie
Intezyne Technologies, Inc.
American College of Radiology Imaging Network
M.D. Anderson Cancer Center
University of Alabama at Birmingham
Lumos Pharma
Lumos Pharma
Merck Sharp & Dohme LLC
National Institutes of Health Clinical Center (CC)